143 related articles for article (PubMed ID: 6851721)
1. Immunologic study on nasopharyngeal carcinoma patients: correlation of in vivo and in vitro reactivity to phytohemagglutinin.
Hsu MM; Lo P
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1983 Feb; 16(1):20-32. PubMed ID: 6851721
[TBL] [Abstract][Full Text] [Related]
2. Phytohemagglutinin skin test: diagnostic value for showing immunodeficiency in patients with cancer.
Sone S; Taoka S; Yata K; Tsubura E; Nakano Y
Gan; 1975 Dec; 66(6):641-8. PubMed ID: 1225717
[TBL] [Abstract][Full Text] [Related]
3. Increased production of tumor necrosis factor-alpha and release of soluble CD4 and CD8 molecules, but decreased responsiveness to phytohemagglutinin in patients with nasopharyngeal carcinoma.
Kuo WR; Yu HS; Chang KL; Juan KH; Jan YS; Yu CL
J Formos Med Assoc; 1994 Jul; 93(7):569-75. PubMed ID: 7866054
[TBL] [Abstract][Full Text] [Related]
4. Response of lymphocyte subpopulations to phytohemagglutinin, concanavalin A and pokeweed mitogen in patients with nasopharyngeal carcinoma.
Hsu MM; Lin BL
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Nov; 18(4):224-31. PubMed ID: 3878769
[TBL] [Abstract][Full Text] [Related]
5. [Immunological examination in patients with brain tumor and the usefulness of PHA skin test (author's transl)].
Imagawa K; Tochio H; Toda I; Hayashi M; Asai A; Nomura T; Miyaji H
No To Shinkei; 1978 Nov; 30(11):1171-6. PubMed ID: 728272
[TBL] [Abstract][Full Text] [Related]
6. Phytohemagglutinin (PHA) skin test. Characterization of immunological properties and clinical application.
Nishido T
Bull Tokyo Med Dent Univ; 1979 Mar; 26(1):43-55. PubMed ID: 371848
[TBL] [Abstract][Full Text] [Related]
7. General immunological status of nasopharyngeal carcinoma patients in Singapore.
Chan SH; Goh EH; Khor TH; Chew TS
IARC Sci Publ (1971); 1978; (20):495-501. PubMed ID: 215531
[TBL] [Abstract][Full Text] [Related]
8. Lymphoproliferative response to membrane extracts of nasopharyngeal carcinoma.
Tsukuda M; Sawaki S; Yanoma S; Yoshimura N; Takei M; Takada M; Kawamura A
Gan; 1980 Aug; 71(4):441-50. PubMed ID: 6253346
[TBL] [Abstract][Full Text] [Related]
9. Characterization of T cell subsets using monoclonal antibodies in nasopharyngeal carcinoma patients.
Hsu MM; Lin BL
Ann Otol Rhinol Laryngol; 1986; 95(3 Pt 1):298-301. PubMed ID: 2940957
[TBL] [Abstract][Full Text] [Related]
10. Rebound phenomenon of phytohemagglutinin skin reactivity in leukemia and malignant lymphoma after chemotherapy.
Sone S; Yata K; Tsubura E
Gan; 1977 Aug; 68(4):483-90. PubMed ID: 616418
[TBL] [Abstract][Full Text] [Related]
11. Response to and concentration of interleukin-2 in patients with nasopharyngeal carcinoma.
Hsu MM; Hsu LW
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 Aug; 22(3):181-5. PubMed ID: 2605977
[TBL] [Abstract][Full Text] [Related]
12. Studies of the nonspecific cellular immune response in patients with urinary bladder carcinoma. I. PHA-induced lymphocyte transformation.
Nishio S; Horii A; Morikawa Y; Kawakita J; Nishijima T; Kishimoto T; Maekawa M
Invest Urol; 1979 Mar; 16(5):336-41. PubMed ID: 429127
[TBL] [Abstract][Full Text] [Related]
13. Impaired general cell-mediated immune functions in vivo and in vitro in patients with nasopharyngeal carcinoma.
Chan SH; Chew TS; Goh EH; Simons MJ; Shanmugaratnam K
Int J Cancer; 1976 Aug; 18(2):139-44. PubMed ID: 955740
[TBL] [Abstract][Full Text] [Related]
14. Antibody to Epstein-Barr virus specific DNase in sera of nasopharyngeal carcinoma and other nine most common cancer patients in Taiwan.
Hsu MM; Chen JY; Liu MY; Lynn TC; Tu SM; Yang CS
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Aug; 17(3):131-7. PubMed ID: 6096088
[TBL] [Abstract][Full Text] [Related]
15. Ontogeny of con A and PHA responses of chicken blood cells in MHC-compatible lines 6(3) and 7(2).
Fredericksen TL; Gilmour DG
J Immunol; 1983 Jun; 130(6):2528-33. PubMed ID: 6854015
[TBL] [Abstract][Full Text] [Related]
16. [Response of human lymphocytes to phytohemagglutinin (PHA) as measured by fluorescence polarization technique--differences between malignant conditions and benign or healthy conditions].
Tenzaki T; Ishiguro T
Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):817-25. PubMed ID: 2778375
[TBL] [Abstract][Full Text] [Related]
17. Delayed skin reactivity of patients with herpetic stromal keratitis.
Ohno S; Kato F; Matsuda H; Hosokawa M; Kobayashi H
Ann Ophthalmol; 1981 Apr; 13(4):483-5. PubMed ID: 7247195
[TBL] [Abstract][Full Text] [Related]
18. PHA skin test-correlation with migration inhibition but not with peripheral blood lymphocytes (PBL) subpopulations. With 1 figure.
Szczylik C; Wiktor-Jedrzejczak W
Allerg Immunol (Leipz); 1981; 27(3):162-7. PubMed ID: 6214937
[TBL] [Abstract][Full Text] [Related]
19. Phytohemagglutinin (PHA) skin test in patients with sarcoidosis.
Kataria YP; LoBuglio AF; Helentjaris T; Bromberg PA
Am Rev Respir Dis; 1975 Oct; 112(4):575-8. PubMed ID: 1200490
[TBL] [Abstract][Full Text] [Related]
20. Biological markers and breast cancer. A multiparametric study. II. Depressed immune competence.
Mandeville R; Lamoureux G; Legault-Poisson S; Poisson R
Cancer; 1982 Oct; 50(7):1280-8. PubMed ID: 6980699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
